Alaska ends Medicaid Fraud litigation with justice for its citizens*

In 2013, Alaska became the ninth state to announce an end to AWP litigation. Through the litigation, Alaska recovered more than $45 million from pharmaceutical companies that had defrauded the state and its citizens.  More than two dozen manufacturers were accused of overcharging the Alaska Medicaid program.

Alaska’s attorney general retained Beasley Allen to represent the state in litigation.

Beasley Allen has represented numerous states in Average Wholesale Price (AWP) Medicaid Fraud litigation, securing more than $1.3 billion in verdicts and settlements.

As a result of AWP litigation, the federal government and state Medicaid programs have recognized the gross abuse of price reporting by pharmaceutical manufacturers in the marketplace.

“These cases have made a significant social change in how our Medicaid program operates,” explains Beasley Allen Shareholder W. Daniel “Dee” Miles, III, head of the firm’s Consumer Fraud section. “The federal government has revamped its pricing formula going forward, and that’s a direct result of this litigation.”

*Beasley Allen does not represent that the same or similar result would be obtained in other cases.

*The amount of some verdicts may have been reduced by post-trial settlement, appeal, or remittitur. Some amounts may have been obtained by default judgment. Some verdicts and settlements were obtained in other states besides Alabama. Beasley Allen does not represent that the same or similar results would be obtained in all cases